Home > Compound List > Product Information
Sulfacytine_Molecular_structure_CAS_17784-12-2)
Click picture or here to close

Sulfacytine

Catalog No. DB01298 Name DrugBank
CAS Number 17784-12-2 Website http://www.ualberta.ca/
M. F. C12H14N4O3S Telephone (780) 492-3111
M. W. 294.32956 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1150

SYNONYMS

IUPAC name
4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzene-1-sulfonamide
IUPAC Traditional name
sulfacytine
Brand Name
Renoquid
Synonyms
Sulfacitinum [inn-latin]
1-ethyl N4-sulfanilylcytosin
Sulfacitina [inn-spanish]
N-sulfanilyl-l-ethylcytosine
1-ethyl-N-sulfanilylcytosine

DATABASE IDS

PubChem CID 5322
PubChem SID 46505483
CAS Number 17784-12-2

PROPERTIES

Solubility 1.75 mg/mL at 37 oC [MERCK INDEX (1996); pH 5]

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections.

Sulfacytine is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Indication Used orally in the treatment of acute urinary tract infections.
Pharmacology Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Affected Organisms
Bacteria
Absorption Well absorbed following oral administration.

REFERENCES